SACC-NE Sessions With Dr. Karin Rosén | Board member of Diamyd Medical

How does Nordic life science innovation translate into global impact? In this episode of the SACC-NE Sessions Podcast, we explore how new discoveries about the immune system are shaping the future of diabetes research.

Moderator Julie Ames speaks with Dr. Karin Rosén, physician-scientist and board member of Diamyd Medical, a Swedish biotech company developing a therapy designed to help preserve the body’s own insulin production. Together, they discuss the science behind immune tolerance, the company’s ongoing Phase 3 clinical trial, and why the U.S. market plays a critical role in scaling Nordic biotech innovation.

Listen to the full episode here.